-+ 0.00%
-+ 0.00%
-+ 0.00%

Zenas BioPharma CEO Leon Moulder acquires 60,000 shares worth $1.07 million

PUBT·04/29/2026 23:21:37
Listen to the news
Zenas BioPharma CEO Leon Moulder acquires 60,000 shares worth $1.07 million
  • Zenas BioPharma CEO Leon O. Moulder Jr. reported open-market purchases of common stock.
  • Tellus BioVentures LLC acquired 60,000 shares at weighted average prices of $18.02, $17.62.
  • Tellus BioVentures holdings rose to 1,786,039 shares held indirectly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-051889), on April 29, 2026, and is solely responsible for the information contained therein.